Critical Care Ourense Research Group. CC-OuRG

Barbeta E, Barreiros C, Forin E, Guzzardella A, Motos A, Fernandez-Barat L,Gabarrus A, Ceccato A, Ferrer R, Riera J, Penuelas O, Lorente JA, deGonzalo-Calvo D, Gonzalez J, Amaya-Villar R, Anon JM, Balan A, Barbera C,Barberan J, Blandino A, Boado MV, Bustamante-Munguira E, Caballero J,Canton-Bulnes ML, Carbajales C, Carbonell N, Catalan-Gonzalez M, Franco N, GalbanC, Gumucio-Sanguino VD, de la Torre MDC, Diaz E, Estella A, Gallego E, Gomez JM,Huerta A, Garcia RNJ, Loza-Vazquez A, Marin-Corral J, Delgado MCM, Martinez A,Martinez I, Lopez J, Albaiceta GM, Nieto MT, Novo MA, Penasco Y, Perez-Garcia F,Ricart P, Rodriguez A, Sagredo V, Sanchez-Miralles A, Sancho S, Roche-Campo F,Socias L, Sole-Violan J, Tamayo L, Trenado J, Ubeda A, Valdivia LJ, Vidal P,Barbe F, Vallverdu J, Torres A; CIBERESUCICOVID Project investigators(COV20/00110, ISCIII). Mechanical power is not associated with mortality inCOVID-19 mechanically ventilated patients. Ann Intensive Care. 2025 Feb25;15(1):27. doi: 10.1186/s13613-025-01430-6. PubMed PMID: 39998751; PubMedCentral PMCID: PMC11861844.

Campos S, Ballesteros MA, Rodrigo E, Lopez Del Moral C, Campos-Juanatey F,Suberviola B, Garcia-Alcalde L, Amaya A, Dominguez-Gil B, Ruiz-San Millan JC,Minambres E. New Donor Selection Criteria Result in Optimal Outcomes of Kidneysfrom Uncontrolled Donation After the Circulatory Determination of Death.Transplant Direct. 2025 Apr 10;11(5):e1790. doi: 10.1097/TXD.0000000000001790.eCollection 2025 May. PubMed PMID: 40740541; PubMed Central PMCID: PMC12310195.

Cuenca Fito E, Gomez-Acebo I, Gonzalez Castro A. Development and validation ofpredictive mortality models in critically ill oncological patients in the ICU: Anurgent need. Med Intensiva (Engl Ed). 2025 Apr 15:502163. doi:10.1016/j.medine.2025.502163. Online ahead of print. No abstract available.PubMed PMID: 40240250.

Cuenca-Fito E, Mayor-Vazquez E. Is it time to measure disease-free survival incritical oncology population? Med Intensiva (Engl Ed). 2025 May;49(5):502157.doi: 10.1016/j.medine.2025.502157. Epub 2025 Feb 24. No abstract available.PubMed PMID: 40000343.

Cuenca-Fito E, Mayor-Vazquez E. Is it time to measure disease-free survival incritical oncology population? Med Intensiva (Engl Ed). 2025 May;49(5):502157.doi: 10.1016/j.medine.2025.502157. Epub 2025 Feb 24. No abstract available.PubMed PMID: 40000343.

Fernandez-Barat L, Motos A, Canseco-Ribas J, Gabarrus A, Lopez-Aladid R,Alvaro-Meca A, Ceccato A, Garcia N, Ferrer M, Battaglini D, Avarez-Napagao S,Garcia-Gasulla D, Ferrer R, de Gonzalo-Calvo D, Lorente JA, Menendez R, PenuelasO, Riera J, Rodriguez A, Amaya Villar R, Anon JM, Balan Marino A, Barbera C,Barberan J, Blandino Ortiz A, Boado MV, Bofill N, Bustamante-Munguira E,Caballero J, Canton-Bulnes ML, Carbajales Perez C, Carbonell N, Catalan-GonzalezM, Del Carmen de la Torre M, Diaz E, Estella A, Figueras A, de Frutos R, FrancoN, Galban C, Gallego E, Garcia Garmendia JL, Gonzalez J, Gomez JM,Gumucio-Sanguino VD, Huerta A, Jorge Garcia RN, Loza-Vazquez A, Marin-Corral J,Martin Delgado MC, Martinez de la Gandara A, Martinez Varela I, Albaiceta GM,Nieto M, Penasco Y, Perez-Bastida L, Perez-Garcia F, Pozo-Laderas JC, Ricart P,Sagredo V, Sanchez-Miralles A, Sancho Chinesta S, Socias L, Sole-Violan J,Suarez-Sipmann F, Tamayo Lomas L, Trenado J, Ubeda A, Jorge Valdivia L, Vidal P,Bermejo-Martin J, Barbe F, Torres A; CIBERESUCICOVID Project Investigators.Outcomes and Predictors of Mortality in Patients with Severe COVID-19 and COPDadmitted to ICU: A multicenter study. Anaesth Crit Care Pain Med. 2025 May22:101558. doi: 10.1016/j.accpm.2025.101558. Online ahead of print. PubMed PMID:40412514.

Garcia-Mateo N, Alvaro-Meca A, Postigo T, Ortega A, de la de la Fuente A,Almansa R, Jorge N, Gonzalez-Gonzalez L, Recio LS, Martinez I, Martin-Vicente M,Munoz-Gomez MJ, Mas V, Vazquez M, Cano O, Velez-Serrano D, Tamayo L, Berezo JA,Herran-Monge R, Blanco J, Enriquez P, Ryan-Murua P, de la Martinez de la GandaraA, Rodriguez C, Andrade G, Bustamante-Munguira E, Renedo Sanchez-Giron G,Cicuendez Avila R, Bustamante-Munguira J, Trapiello W, Gallego Curto E,Ubeda-Iglesias A, Salgado-Villen M, Berruguilla-Perez E, Del de la Torre MDC,Guell E, Casadiego F, Estella A, Recuerda Nunez M, Sanchez Calvo JM,Campos-Fernandez S, Penasco-Martin Y, Garcia Unzueta MT, Martinez Varela I, BouzaVieiro MT, Perez-Garcia F, Moreno-Romero A, Socias L, Lopez Messa J, PerezBastida L, Vidal-Cortes P, Del Del Rio-Carbajo L, Del Nieto Del Olmo J,Prol-Silva E, Sagredo Meneses V, Albala Martinez N, Gonzalez-Rivera M, Gomez JM,Carbonell N, Blasco ML, de de Gonzalo-Calvo D, Gonzalez J, Caballero J, BarberaC, Martin Delgado MC, Valdivia LJ, Martin-Lopez C, Nieto MT, Jorge Garcia RN,Maseda E, Loza-Vazquez A, Eiros JM, Motos A, Fernandez-Barat L, Casenco-Ribas J,Ceccato A, Barbe F, Kelvin DJ, Bermejo-Martin JF, Tedim AP, Resino S, Torres A.Machine-learning analysis identifies «elite» viral controllers with increasedsurvival and homeostatic responses in critical COVID-19. Clin Transl Med. 2025May;15(5):e70241. doi: 10.1002/ctm2.70241. No abstract available. PubMed PMID:40285348; PubMed Central PMCID: PMC12031886.

Garcia-Mateo N, Alvaro-Meca A, Postigo T, Ortega A, de la de la Fuente A,Almansa R, Jorge N, Gonzalez-Gonzalez L, Recio LS, Martinez I, Martin-Vicente M,Munoz-Gomez MJ, Mas V, Vazquez M, Cano O, Velez-Serrano D, Tamayo L, Berezo JA,Herran-Monge R, Blanco J, Enriquez P, Ryan-Murua P, de la Martinez de la GandaraA, Rodriguez C, Andrade G, Bustamante-Munguira E, Renedo Sanchez-Giron G,Cicuendez Avila R, Bustamante-Munguira J, Trapiello W, Gallego Curto E,Ubeda-Iglesias A, Salgado-Villen M, Berruguilla-Perez E, Del de la Torre MDC,Guell E, Casadiego F, Estella A, Recuerda Nunez M, Sanchez Calvo JM,Campos-Fernandez S, Penasco-Martin Y, Garcia Unzueta MT, Martinez Varela I, BouzaVieiro MT, Perez-Garcia F, Moreno-Romero A, Socias L, Lopez Messa J, PerezBastida L, Vidal-Cortes P, Del Del Rio-Carbajo L, Del Nieto Del Olmo J,Prol-Silva E, Sagredo Meneses V, Albala Martinez N, Gonzalez-Rivera M, Gomez JM,Carbonell N, Blasco ML, de de Gonzalo-Calvo D, Gonzalez J, Caballero J, BarberaC, Martin Delgado MC, Valdivia LJ, Martin-Lopez C, Nieto MT, Jorge Garcia RN,Maseda E, Loza-Vazquez A, Eiros JM, Motos A, Fernandez-Barat L, Casenco-Ribas J,Ceccato A, Barbe F, Kelvin DJ, Bermejo-Martin JF, Tedim AP, Resino S, Torres A.Machine-learning analysis identifies «elite» viral controllers with increasedsurvival and homeostatic responses in critical COVID-19. Clin Transl Med. 2025May;15(5):e70241. doi: 10.1002/ctm2.70241. No abstract available. PubMed PMID:40285348; PubMed Central PMCID: PMC12031886.

González-Castro A, Iglesias D, Peñasco Y, Huertas Marín C, Cuenca-Fito E, Dierssen-Soto T, Wallmann R, Ferrero-Fraile R, González C, Rodríguez-Borregán JC. Impacto de la vacunación frente al COVID-19 en los costos hospitalarios en los enfermos ingresados en una unidad de cuidados intensivos durante la cuarta, quinta y sexta oleada de la pandemia. Med Intensiva. 2025; (Disponible online 1 jul 2025).

Huertas Marín C, Dierssen-Soto T, Peñasco Y, Cuenca-Fito E, Wallmann R, Ferrero-Fraile R, et al. Modelo de regresión logística para predecir el mayor coste hospitalario en los enfermos que ingresaron en UCI-COVID durante la pandemia. Resultados en un hospital de tercer nivel. Med Intensiva. 2025; (Disponible online 1 jul 2025).

Kreitmann L, Bayon C, Martin-Loeches I, Povoa P, Salluh J, Rouze A, Moreau AS,Duhamel A, Labreuche J, Nseir S; Type of iMmunosuppression and the Incidence,Microbiology, and OutcomeS of ventilator-Associated lower respiratory tractinfections (MIMOSA) Study Group. Association Between Type of Immunosuppressionand the Incidence, Microbiology, and Outcomes of Bacterial Ventilator-AssociatedLower Respiratory Tract Infections: A Retrospective Multicenter Study. Crit CareMed. 2025 May 1;53(5):e1080-e1094. doi: 10.1097/CCM.0000000000006615. Epub 2025Feb 21. PubMed PMID: 39982132.

Mayor-Vázquez E, Cuenca F, Marcos-Neira P, Díaz-Lagares C, Gomila-Sintes C, Albalay N, García-Roche A, Castro P. Síndrome de liberación de citocinas y síndrome hemofagocítico asociados a inmunoterapia: una revisión narrativa. Med Intensiva. 2025; (Disponible online 1 jul 2025).

Scheer CS, Giamarellos-Bourboulis EJ, Ferrer R, Idelevich EA, Annane D,Artigas A, Aslan AT, Bottari G, Bouma HR, Cerny V, Curic Radivojevic R, Dakou K,Dewitte K, Elbahnasawy M, Grundling M, Gurjar M, Hastbacka J, Kyprianou M, LaribiS, Lassen A, Lebedinskii K, Maca J, Malbrain MLNG, Monti G, Ostermann M, OsthoffM, Paiva JA, Sabbatucci M, Smiechowicz J, Stefan MG, Vollmer M, Vukovic N,Zaragkoulias K, Reinhart K, Linder A, Filipescu D; European Sepsis Care StudyGroup. Status of Sepsis Care in European Hospitals: Results from an InternationalCross-Sectional Survey. Am J Respir Crit Care Med. 2025 Apr;211(4):587-599. doi:10.1164/rccm.202406-1167OC. PubMed PMID: 39787606; PubMed Central PMCID:PMC12005017.

Veloso MA, González Chana B, Serrulla Blanco M, Serrulla Rech F. Manipulación y obtención postmortem de información de dispositivos electrónicos cardioimplantables. Boletín Galego de Medicina Legal e Forense nº37. Junio 2025.

Vidal-Cortes P, Campos-Fernandez S, Cuenca-Fito E, Del Rio-Carbajo L,Fernandez-Ugidos P, Lopez-Ciudad VJ, Nieto-Del Olmo J, Rodriguez-Vazquez A,Tizon-Varela AI. Difficult-to-Treat Pseudomonas aeruginosa Infections inCritically Ill Patients: A Comprehensive Review and Treatment Proposal.Antibiotics (Basel). 2025 Feb 11;14(2):178. doi: 10.3390/antibiotics14020178.PubMed PMID: 40001421; PubMed Central PMCID: PMC11851922.

Vidal-Cortes P, Campos-Fernandez S, Cuenca-Fito E, Del Rio-Carbajo L,Fernandez-Ugidos P, Lopez-Ciudad VJ, Nieto-Del Olmo J, Rodriguez-Vazquez A,Tizon-Varela AI. Difficult-to-Treat Pseudomonas aeruginosa Infections inCritically Ill Patients: A Comprehensive Review and Treatment Proposal.Antibiotics (Basel). 2025 Feb 11;14(2):178. doi: 10.3390/antibiotics14020178.PubMed PMID: 40001421; PubMed Central PMCID: PMC11851922.

Vidal-Cortés P, Gómez-López R, Rodríguez-Ruiz E, Fernández-Ugidos P, Eiras Abalde F, del Río-Carbajo L, et al. Organización de los Servicios de Medicina Intensiva para una asistencia de calidad. Recomendaciones de la SOGAMIUC utilizando una metodología Delphi (con el respaldo de SEMICYUC, SAMI, SBMICIUC, SOCAMICYUC, SNMIUC, SCLMICYUC, SOCMIC, SEXMICYUC, SOMIUC). Med Intensiva [Internet]. [citado 5 de septiembre de 2025]; Disponible en: http://www.medintensiva.org/es-organizacion-servicios-medicina-intensiva-una-avance-S0210569125001317
Enlace

Ceccato A, Forne C, Bos LD, Camprubi-Rimblas M, Areny-Balaguero A,Campana-Duel E, Quero S, Diaz E, Roca O, De Gonzalo-Calvo D, Fernandez-Barat L,Motos A, Ferrer R, Riera J, Lorente JA, Penuelas O, Menendez R, Amaya-Villar R,Anon JM, Balan-Marino A, Barbera C, Barberan J, Blandino-Ortiz A, Boado MV,Bustamante-Munguira E, Caballero J, Carbajales C, Carbonell N, Catalan-GonzalezM, Franco N, Galban C, Gumucio-Sanguino VD, de la Torre MDC, Estella A, GallegoE, Garcia-Garmendia JL, Garnacho-Montero J, Gomez JM, Huerta A, Jorge-Garcia RN,Loza-Vazquez A, Marin-Corral J, Martinez de la Gandara A, Martin-Delgado MC,Martinez-Varela I, Messa JL, Muniz-Albaiceta G, Nieto MT, Novo MA, Penasco Y,Pozo-Laderas JC, Perez-Garcia F, Ricart P, Roche-Campo F, Rodriguez A, Sagredo V,Sanchez-Miralles A, Sancho-Chinesta S, Socias L, Sole-Violan J, Suarez-Sipmann F,Tamayo-Lomas L, Trenado J, Ubeda A, Valdivia LJ, Vidal P, Bermejo J, Gonzalez J,Barbe F, Calfee CS, Artigas A, Torres A; CIBERESUCICOVID Project. ClusteringCOVID-19 ARDS patients through the first days of ICU admission. An analysis ofthe CIBERESUCICOVID Cohort. Crit Care. 2024 Mar 21;28(1):91. doi:10.1186/s13054-024-04876-5. PubMed PMID: 38515193; PubMed Central PMCID:PMC10958830.

Cuenca Fito E, Gonzalez Castro A, Gomez Acebo I. Reasons for refusal ofadmission to the ICU in oncological population and their association with 6-monthmortality. Med Intensiva (Engl Ed). 2024 Oct;48(10):616-620. doi:10.1016/j.medine.2024.05.013. Epub 2024 Jun 25. No abstract available. PubMedPMID: 38918161.

Fernandez-Torre JL, Paramio-Paz A, Campos-Fernandez S, Rivera-Sanchez M,Orizaola P, Hernandez-Hernandez MA. Typical Absence Status Epilepticus in LaterLife Precipitated by Spirometry. Can J Neurol Sci. 2024 Mar;51(2):333-335. doi:10.1017/cjn.2023.9. Epub 2023 Jan 20. No abstract available. PubMed PMID:36657985.

Gomez Estanga S, Cuenca Fito E, Galeiras R. Blast lung injury in recreationaldiving. Med Clin (Barc). 2024 Apr 26;162(8):401-402. doi:10.1016/j.medcli.2023.11.005. Epub 2023 Dec 1. No abstract available. English,Spanish. PubMed PMID: 38042735.

Gonzalez-Castro A, Cuenca Fito E, Huertas Martin C, Penasco Y, FajardoCampoverdi A. Analysis of energy load values in mechanical ventilation in obesepatients with hypoxemic respiratory failure secondary to SARS-CoV-2. MedIntensiva (Engl Ed). 2024 Nov;48(11):663-666. doi: 10.1016/j.medine.2024.06.018.Epub 2024 Jul 29. No abstract available. PubMed PMID: 39079774.

Gonzalez-Castro A, Fernandez A, Cuenca-Fito E, Penasco Y, Cena J, RodriguezBorregan JC. Association between different corticosteroid regimens used in severeSARS-CoV-2 infection and short-term mortality: retrospective cohort study. RevEsp Anestesiol Reanim (Engl Ed). 2024 May;71(5):379-386. doi:10.1016/j.redare.2024.02.012. Epub 2024 Feb 21. PubMed PMID: 38395302.

Gonzalez-Castro A, Huertas Martin C, Cuenca Fito E, Penasco Y, Gonzalez C,Rodriguez Borregan JC. Duration of the first prone positioning maneuver and itsassociation with 90-day mortality in patients with acute respiratory failure dueto COVID-19: A retrospective study of time terciles. Med Intensiva (Engl Ed).2024 Aug;48(8):457-466. doi: 10.1016/j.medine.2024.04.009. Epub 2024 Apr 30.PubMed PMID: 38688818.

Gonzalez-Castro A, Huertas Martin C, Cuenca Fito E, Penasco Y, Gonzalez C,Rodriguez Borregan JC. Duration of the first prone positioning maneuver and itsassociation with 90-day mortality in patients with acute respiratory failure dueto COVID-19: A retrospective study of time terciles. Med Intensiva (Engl Ed).2024 Aug;48(8):457-466. doi: 10.1016/j.medine.2024.04.009. Epub 2024 Apr 30.PubMed PMID: 38688818.

Minguito-Carazo C, Martinez-Alday JD, Martinez-Sande JL, Garcia Seara J,Fernandez Lopez XA, Shangutov O, Larrabide Eguren I, Gonzalez-Ferrero T,Elices-Teja J, Perez Veloso MA, Gonzalez-Juanatey JR, Rodriguez-Manero M. Effectof age on clinical impact and mid-term denervation in patients undergoingcardioneuroablation. Sci Rep. 2024 Nov 11;14(1):27546. doi:10.1038/s41598-024-78665-z. PubMed PMID: 39528539; PubMed Central PMCID:PMC11554643.

Monzo-Gallo P, Lopera C, Badia-Tejero AM, Machado M, Garcia-Rodriguez J,Vidal-Cortes P, Merino E, Calderon J, Fortun J, Palacios-Baena ZR, Peman J,Sanchis JR, Aguilar-Guisado M, Gudiol C, Ramos JC, Sanchez-Romero I,Martin-Davila P, Lopez-Cortes LE, Salavert M, Ruiz-Camps I, Chumbita M, AielloTF, Peyrony O, Puerta-Alcalde P, Soriano A, Marco F, Garcia-Vidal C. Corrigendumto «Safety and effectiveness of isavuconazole in real-life non-neu tropenicpatients» [International Journal of Infectious Diseases 144 (2024) 107070]. Int JInfect Dis. 2024 Sep;146:107188. doi: 10.1016/j.ijid.2024.107188. Epub 2024 Jul26. No abstract available. PubMed PMID: 39067149.

Monzo-Gallo P, Lopera C, Badia-Tejero AM, Machado M, Garcia-Rodriguez J,Vidal-Cortes P, Merino E, Calderon J, Fortun J, Palacios-Baena ZR, Peman J,Sanchis JR, Aguilar-Guisado M, Gudiol C, Ramos JC, Sanchez-Romero I,Martin-Davila P, Lopez-Cortes LE, Salavert M, Ruiz-Camps I, Chumbita M, AielloTF, Peyrony O, Puerta-Alcalde P, Soriano A, Marco F, Garcia-Vidal C. Safety andeffectiveness of isavuconazole in real-life non-neutropenic patients. Int JInfect Dis. 2024 Jul;144:107070. doi: 10.1016/j.ijid.2024.107070. Epub 2024 Apr23. PubMed PMID: 38663477.

Ruiz Mateas F, Perez MA, Garcia Lopez F, Gonzalez S, Anguera Camos I, GusiTragant G, Robledo Irranitu M, Fernandez Lozano I, Martinez JG, Alzueta RodriguezFJ. Magnetic resonance imaging in patients with cardiac implantable electronicdevices: the RESONANCE Spanish registry. Europace. 2024 Nov 1;26(11):euae277.doi: 10.1093/europace/euae277. PubMed PMID: 39498837; PubMed Central PMCID:PMC11572718.

Subira C, Rognoni G, Baquerizo H, Garcia C, Cabanes S, de la Torre M, QuevedoB, Pedros C, Tizon AI, Murillo N, Parro L, Eiras F, Rialp G, Altaba S,Gonzalez-Castro A, Pacheco AF, Bayoumi P, Gomez-Medrano N, Vallverdu I, Higon A,Navarro MD, Falcon A, Keough E, Arizo D, Martinez JF, Duran N, Rodriguez R,Popoviciu-Koborzan MR, Guerrero I, Concha P, Barral P, Batlle M, Cano S,Garcia-Castrillon S, Andorra X, Tua Y, Arnau A, Fernandez R. Effect of lungvolume preservation during spontaneous breathing trial on successful extubationin patients receiving mechanical ventilation: protocol for a multicenter clinicaltrial. Trials. 2024 Jul 16;25(1):481. doi: 10.1186/s13063-024-08297-1. PubMedPMID: 39014430; PubMed Central PMCID: PMC11251308.

Bermejo-Martin JF, Garcia-Mateo N, Motos A, Resino S, Tamayo L, Ryan Murua P,Bustamante-Munguira E, Gallego Curto E, Ubeda-Iglesias A, de la Torre MDC,Estella A, Campos-Fernandez S, Martinez Varela I, Perez-Garcia F, Socias L, LopezMessa J, Vidal-Cortes P, Sagredo Meneses V, Gonzalez-Rivera M, Carbonell N, deGonzalo-Calvo D, Martin Delgado MC, Valdivia LJ, Martin-Lopez C, Jorge Garcia RN,Maseda E, Loza-Vazquez A, Kelvin DJ, Barbe F, Torres A; CIBERES-UCI-COVID Group.Effect of viral storm in patients admitted to intensive care units with severeCOVID-19 in Spain: a multicentre, prospective, cohort study. Lancet Microbe. 2023Jun;4(6):e431-e441. doi: 10.1016/S2666-5247(23)00041-1. Epub 2023 Apr 25. PubMedPMID: 37116517; PubMed Central PMCID: PMC10129133.

Candel FJ, Salavert M, Estella A, Ferrer M, Ferrer R, Gamazo JJ, Garcia-VidalC, Del Castillo JG, Gonzalez-Ramallo VJ, Gordo F, Miron-Rubio M, Perez-PallaresJ, Pitart C, Del Pozo JL, Ramirez P, Rascado P, Reyes S, Ruiz-Garbajosa P,Suberviola B, Vidal P, Zaragoza R. Ten Issues to Update in Nosocomial orHospital-Acquired Pneumonia: An Expert Review. J Clin Med. 2023 Oct14;12(20):6526. doi: 10.3390/jcm12206526. PubMed PMID: 37892664; PubMed CentralPMCID: PMC10607368.

Cercenado E, Rodriguez-Bano J, Alfonso JL, Calbo E, Escosa L, Fernandez-PoloA, Garcia-Rodriguez J, Garnacho J, Gil-Navarro MV, Grau S, Gudiol C, HorcajadaJP, Larrosa N, Martinez C, Molina J, Nuvials X, Oliver A, Pano-Pardo JR,Perez-Rodriguez MT, Ramirez P, Rey-Biel P, Vidal P, Retamar-Gentil P.Antimicrobial stewardship in hospitals: Expert recommendation guidance documentfor activities in specific populations, syndromes and other aspects (PROA-2) fromSEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP. Enferm Infecc Microbiol Clin (Engl Ed).2023 Apr;41(4):238-242. doi: 10.1016/j.eimce.2022.05.013. Epub 2023 Jan 5. PubMedPMID: 36610836.

Cilloniz C, Motos A, Castaneda T, Gabarrus A, Barbe F, Torres A;CIBERESUCICOVID Project (COV20/00110, ISCIII). Remdesivir and survival outcomesin critically ill patients with COVID-19: A multicentre observational cohortstudy. J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.027. Epub2022 Dec 31. No abstract available. PubMed PMID: 36596315; PubMed Central PMCID:PMC9804970.

Cuenca Fito E, Gonzalez-Castro A, Gomez Acebo I. Predictive value of theAPACHEII and SOFA scales in the mortality of cancer patients in intensive care.Med Clin (Barc). 2023 Dec 22;161(12):547-548. doi: 10.1016/j.medcli.2023.07.016.Epub 2023 Aug 10. No abstract available. English, Spanish. PubMed PMID: 37573170.

de Gonzalo-Calvo D, Molinero M, Benitez ID, Perez-Pons M, Garcia-Mateo N,Ortega A, Postigo T, Garcia-Hidalgo MC, Belmonte T, Rodriguez-Munoz C, GonzalezJ, Torres G, Gort-Paniello C, Moncusi-Moix A, Estella A, Tamayo Lomas L, Martinezde la Gandara A, Socias L, Penasco Y, de la Torre MDC, Bustamante-Munguira E,Gallego Curto E, Martinez Varela I, Martin Delgado MC, Vidal-Cortes P, LopezMessa J, Perez-Garcia F, Caballero J, Anon JM, Loza-Vazquez A, Carbonell N,Marin-Corral J, Jorge Garcia RN, Barbera C, Ceccato A, Fernandez-Barat L, FerrerR, Garcia-Gasulla D, Lorente-Balanza JA, Menendez R, Motos A, Penuelas O, RieraJ, Bermejo-Martin JF, Torres A, Barbe F. A blood microRNA classifier for theprediction of ICU mortality in COVID-19 patients: a multicenter validation study.Respir Res. 2023 Jun 17;24(1):159. doi: 10.1186/s12931-023-02462-x. PubMed PMID:37328754; PubMed Central PMCID: PMC10276486.

Galli F, Bindo F, Motos A, Fernandez-Barat L, Barbeta E, Gabarrus A, CeccatoA, Bermejo-Martin JF, Ferrer R, Riera J, Penuelas O, Lorente JA, de Gonzalo-CalvoD, Menendez R, Gonzalez J, Misuraca S, Palomeque A, Amaya-Villar R, Anon JM,Balan Marino A, Barbera C, Barberan J, Blandino Ortiz A, Bustamante-Munguira E,Caballero J, Canton-Bulnes ML, Carbajales Perez C, Carbonell N, Catalan-GonzalezM, de Frutos R, Franco N, Galban C, Lopez Lago A, Gumucio-Sanguino VD, de laTorre MDC, Diaz E, Estella A, Gallego Curto E, Garcia-Garmendia JL, Gomez JM,Huerta A, Jorge Garcia RN, Loza-Vazquez A, Marin-Corral J, Martin Delgado MC,Martinez de la Gandara A, Martinez Varela I, Lopez Messa J, M Albaiceta G, NietoMT, Novo MA, Penasco Y, Perez-Garcia F, Pozo-Laderas JC, Ricart P, Sagredo V,Sanchez-Miralles A, Sancho Chinesta S, Roche-Campo F, Socias L, Sole-Violan J,Suarez-Sipmann F, Tamayo Lomas L, Trenado J, Ubeda A, Valdivia LJ, Vidal P, BoadoMV, Rodriguez A, Antonelli M, Blasi F, Barbe F, Torres A; CIBERESUCICOVID Projectinvestigators (COV20/00110, ISCIII). Procalcitonin and C-reactive protein to ruleout early bacterial coinfection in COVID-19 critically ill patients. IntensiveCare Med. 2023 Aug;49(8):934-945. doi: 10.1007/s00134-023-07161-1. Epub 2023 Jul28. PubMed PMID: 37507573; PubMed Central PMCID: PMC10425511.

Gonzalez J, de Batlle J, Benitez ID, Torres G, Santisteve S, Targa ADS,Gort-Paniello C, Moncusi-Moix A, Aguila M, Seck F, Ceccato A, Ferrer R, Motos A,Riera J, Fernandez L, Menendez R, Lorente JA, Penuelas O, Garcia-Gasulla D,Penasco Y, Ricart P, Abril Palomares E, Aguilera L, Rodriguez A, Boado Varela MV,Betere B, Pozo-Laderas JC, Sole-Violan J, Salvador-Adell I, Novo MA, Barberan J,Amaya Villar R, Garnacho-Montero J, Gomez JM, Blandino Ortiz A, Tamayo Lomas L,Ubeda A, Catalan-Gonzalez M, Sanchez-Miralles A, Martinez Varela I, Jorge GarciaRN, Franco N, Gumucio-Sanguino VD, Bustamante-Munguira E, Valdivia LJ, CaballeroJ, Gallego E, Rodriguez C, Castellanos-Ortega A, Trenado J, Marin-Corral J,Albaiceta GM, de la Torre MDC, Loza-Vazquez A, Vidal P, Anon JM, Carbajales PerezC, Sagredo V, Carbonell N, Socias L, Barbera C, Estella A, Diaz E, deGonzalo-Calvo D, Torres A, Barbe F; CIBERESUCICOVID Project. Key FactorsAssociated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19Patients. Arch Bronconeumol. 2023 Apr;59(4):205-215. doi:10.1016/j.arbres.2022.12.017. Epub 2023 Jan 7. PubMed PMID: 36690515; PubMedCentral PMCID: PMC9824938.

Gonzalez-Castro A, Cuenca Fito E, Fernandez A, Penasco Y, Modesto I Alport V,Medina Villanueva A, Fajardo A, Escude-Acha P. [Cost-effectiveness analysis highflow oxygen therapy in the treatment of SARS-CoV-2 pneumonia]. J Healthc QualRes. 2023 May-Jun;38(3):152-157. doi: 10.1016/j.jhqr.2022.10.004. Epub 2022 Oct24. Spanish. PubMed PMID: 36400703; PubMed Central PMCID: PMC9595363.

Gonzalez-Castro A, Cuenca Fito E, Fernandez A, Penasco Y, Modesto I Alport V,Medina Villanueva A, Fajardo A, Escude-Acha P. [Cost-effectiveness analysis highflow oxygen therapy in the treatment of SARS-CoV-2 pneumonia]. J Healthc QualRes. 2023 May-Jun;38(3):152-157. doi: 10.1016/j.jhqr.2022.10.004. Epub 2022 Oct24. Spanish. PubMed PMID: 36400703; PubMed Central PMCID: PMC9595363.

Gonzalez-Castro A, Cuenca Fito E, Fernandez-Rodriguez A, Escudero Acha P,Rodriguez Borregan JC, Penasco Y. Mechanical power greater than 17 joules/min inpatients with respiratory failure secondary to SARS-CoV-2 infection. MedIntensiva (Engl Ed). 2023 Feb;47(2):115-117. doi: 10.1016/j.medine.2022.05.015.Epub 2022 Oct 27. No abstract available. PubMed PMID: 36543650; PubMed CentralPMCID: PMC9606038.

Gonzalez-Castro A, Cuenca Fito E, Gonzalez C. Acute respiratory distresssyndrome: a definition on the line. Med Intensiva (Engl Ed). 2023 Apr;47(4):242.doi: 10.1016/j.medine.2023.01.001. Epub 2023 Jan 3. No abstract available. PubMedPMID: 36653208.

Gonzalez-Castro A, Cuenca-Fito E, Penasco Y, Fernandez A, Huertas Marin C,Dierssen-Soto T, Ferrero-Franco R, Rodriguez-Borregan JC. [Analysis ofcharacteristics of elderly patients admitted to an intensive care unit during sixwaves of the SARS-CoV-2 pandemic: Implications for medical care]. Rev Esp GeriatrGerontol. 2023 Jul-Aug;58(4):101377. doi: 10.1016/j.regg.2023.101377. Epub 2023Jun 20. Spanish. PubMed PMID: 37451199; PubMed Central PMCID: PMC10281214.

Gonzalez-Castro A, Ferrero-Franco R, Cuenca Fito E. Social networks andscientific rigor: A new battle on the horizon? Med Intensiva (Engl Ed). 2023Jun;47(6):357-358. doi: 10.1016/j.medine.2023.03.007. Epub 2023 Mar 21. Noabstract available. PubMed PMID: 36948925.

Gonzalez-Castro A, Ferrero-Franco R, Cuenca Fito E. Social networks andscientific rigor: A new battle on the horizon? Med Intensiva (Engl Ed). 2023Jun;47(6):357-358. doi: 10.1016/j.medine.2023.03.007. Epub 2023 Mar 21. Noabstract available. PubMed PMID: 36948925.

Gonzalez-Castro A, Modesto I Alapont V, Cuenca Fito E, Penasco Y, EscuderoAcha P, Huertas Martin C, Rodriguez Borregan JC. The Bayes factor in the analysisof mechanical power in patients with severe respiratory failure due toSARS-CoV-2. Med Intensiva (Engl Ed). 2023 Nov;47(11):621-628. doi:10.1016/j.medine.2023.03.016. Epub 2023 Apr 3. PubMed PMID: 37117098; PubMedCentral PMCID: PMC10067457.

Gonzalez-Castro A, Modesto I Alapont V, Cuenca Fito E, Penasco Y, EscuderoAcha P, Huertas Martin C, Rodriguez Borregan JC. The Bayes factor in the analysisof mechanical power in patients with severe respiratory failure due toSARS-CoV-2. Med Intensiva (Engl Ed). 2023 Nov;47(11):621-628. doi:10.1016/j.medine.2023.03.016. Epub 2023 Apr 3. PubMed PMID: 37117098; PubMedCentral PMCID: PMC10067457.

Gonzalez-Castro A, Modesto I Alapont V, Cuenca Fito E, Penasco Y, EscuderoAcha P, Huertas Martin C, Rodriguez Borregan JC. [The Bayes factor in theanalysis of mechanical power in patients with severe respiratory failure due toSARS-CoV-2]. Med Intensiva. 2023 Mar 22. doi: 10.1016/j.medin.2023.03.005. Onlineahead of print. Spanish. PubMed PMID: 37359241; PubMed Central PMCID:PMC10030329.

Moreno G, Ruiz-Botella M, Martin-Loeches I, Gomez Alvarez J, Jimenez HerreraM, Bodi M, Armestar F, Marques Parra A, Estella A, Trefler S, Jorge Garcia R,Murcia Paya J, Vidal Cortes P, Diaz E, Ferrer R, Albaya-Moreno A, Socias-CrespiL, Bonell Goytisolo JM, Sancho Chinesta S, Loza A, Forcelledo Espina L, PozoLaderas JC, deAlba-Aparicio M, Sanchez Montori L, Vallverdu Perapoch I, HidalgoV, Fraile Gutierrez V, Casamitjana Ortega AM, Martin Serrano F, Nieto M, BlascoCortes M, Marin-Corral J, Sole-Violan J, Rodriguez A; on behalf COVID-19 SEMICYUCWorking Group. A differential therapeutic consideration for use ofcorticosteroids according to established COVID-19 clinical phenotypes incritically ill patients. Med Intensiva (Engl Ed). 2023 Jan;47(1):23-33. doi:10.1016/j.medine.2021.10.016. Epub 2022 Oct 19. PubMed PMID: 36272908; PubMedCentral PMCID: PMC9579897.

Moreno G, Ruiz-Botella M, Martin-Loeches I, Gomez Alvarez J, Jimenez HerreraM, Bodi M, Armestar F, Marques Parra A, Estella A, Trefler S, Jorge Garcia R,Murcia Paya J, Vidal Cortes P, Diaz E, Ferrer R, Albaya-Moreno A, Socias-CrespiL, Bonell Goytisolo JM, Sancho Chinesta S, Loza A, Forcelledo Espina L, PozoLaderas JC, deAlba-Aparicio M, Sanchez Montori L, Vallverdu Perapoch I, HidalgoV, Fraile Gutierrez V, Casamitjana Ortega AM, Martin Serrano F, Nieto M, BlascoCortes M, Marin-Corral J, Sole-Violan J, Rodriguez A; on behalf COVID-19 SEMICYUCWorking Group. A differential therapeutic consideration for use ofcorticosteroids according to established COVID-19 clinical phenotypes incritically ill patients. Med Intensiva. 2023 Jan;47(1):23-33. doi:10.1016/j.medin.2021.10.002. Epub 2021 Oct 26. PubMed PMID: 34720310; PubMedCentral PMCID: PMC8547942.

Riera J, Barbeta E, Tormos A, Mellado-Artigas R, Ceccato A, Motos A,Fernandez-Barat L, Ferrer R, Garcia-Gasulla D, Penuelas O, Lorente JA, MenendezR, Roca O, Palomeque A, Ferrando C, Sole-Violan J, Novo M, Boado MV, Tamayo L,Estella A, Galban C, Trenado J, Huerta A, Loza A, Aguilera L, Garcia GarmendiaJL, Barbera C, Gumucio V, Socias L, Franco N, Valdivia LJ, Vidal P, Sagredo V,Ruiz-Garcia AL, Martinez Varela I, Lopez J, Pozo JC, Nieto M, Gomez JM, BlandinoA, Valledor M, Bustamante-Munguira E, Sanchez-Miralles A, Penasco Y, Barberan J,Ubeda A, Amaya-Villar R, Martin MC, Jorge R, Caballero J, Marin J, Anon JM,Suarez Sipmann F, Albaiceta GM, Castellanos-Ortega A, Adell-Serrano B, Catalan M,Martinez de la Gandara A, Ricart P, Carbajales C, Rodriguez A, Diaz E, de laTorre MC, Gallego E, Canton-Bulnes L, Carbonell N, Gonzalez J, de Gonzalo-CalvoD, Barbe F, Torres A; CIBERESUCICOVID Consortium. Effects of intubation timing inpatients with COVID-19 throughout the four waves of the pandemic: a matchedanalysis. Eur Respir J. 2023 Mar 2;61(3):2201426. doi:10.1183/13993003.01426-2022. Print 2023 Mar. PubMed PMID: 36396142; PubMedCentral PMCID: PMC9686319.

Rodriguez-Borregan JC, Cuenca-Fito E, Penasco Y, Huertas Marin C,Dierssen-Soto T, Fernandez A, Ferrero-Franco R, Gonzalez-Castro A. Retrospectivestudy of the effect of vaccination against SARS-CoV-2 in seriously ill patientsadmitted to an intensive care unit. Med Clin (Barc). 2023 Sep 8;161(5):199-204.doi: 10.1016/j.medcli.2023.04.022. Epub 2023 May 9. English, Spanish. PubMedPMID: 37244858; PubMed Central PMCID: PMC10167265.

Sanchez-Arguiano MJ, Minambres E, Cuenca-Fito E, Suberviola B,Buron-Mediavilla FJ, Ballesteros MA. Chronic critical illness after traumainjury: outcomes and experience in a trauma center. Acta Chir Belg. 2023Dec;123(6):618-624. doi: 10.1080/00015458.2022.2106626. Epub 2022 Aug 3. PubMedPMID: 35881765.

Vidal-Cortes P, Nieto Del Olmo J, Tizon Varela AI, Seoane Fernandez E, EirasAbalde F, Blanco Chapela J, Larranaga Sigwald L, Suarez Fernandez DE, FernandezUgidos P, Del Rio Carbajo L. [Bacterial coinfection in the critically-illCOVID-19 patient: incidence, impact and need for antimicrobial therapy]. Rev EspQuimioter. 2023 Dec;36(6):612-620. doi: 10.37201/req/060.2023. Epub 2023 Sep 25.Spanish. PubMed PMID: 37743661; PubMed Central PMCID: PMC10710676.

Vidal-Cortes P, Nieto Del Olmo J, Tizon Varela AI, Seoane Fernandez E, EirasAbalde F, Blanco Chapela J, Larranaga Sigwald L, Suarez Fernandez DE, FernandezUgidos P, Del Rio Carbajo L. [Bacterial coinfection in the critically-illCOVID-19 patient: incidence, impact and need for antimicrobial therapy]. Rev EspQuimioter. 2023 Dec;36(6):612-620. doi: 10.37201/req/060.2023. Epub 2023 Sep 25.Spanish. PubMed PMID: 37743661; PubMed Central PMCID: PMC10710676.

Pano-Pardo JR, Rodilla EM, Sacristan SC, Saldana JLC, Parraga LP, Leon JLDP,Genti PR, Oviedo AR, Jaen MJT, Vidal-Cortes P, Sanz CC. Management of patientswith suspected or confirmed antibiotic allergy. Executive summary of guidancefrom the Spanish Society of Infectious Diseases and Clinical Microbiology(SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), theSpanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of IntensiveMedicine and Coronary Care Units (SEMICYUC). Enferm Infecc Microbiol Clin (EnglEd). 2023 Mar;41(3):181-186. doi: 10.1016/j.eimce.2022.08.010. Epub 2023 Jan 25.PubMed PMID: 36707291.

Andaluz-Ojeda D, Vidal-Cortes P, Aparisi Sanz A, Suberviola B, Del Rio CarbajoL, Nogales Martin L, Prol Silva E, Nieto Del Olmo J, Barberan J, Cusacovich I.Immunomodulatory therapy for the management of critically ill patients withCOVID-19: A narrative review. World J Crit Care Med. 2022 Jul 9;11(4):269-297.doi: 10.5492/wjccm.v11.i4.269. eCollection 2022 Jul 9. PubMed PMID: 36051937;PubMed Central PMCID: PMC9305685.

Benitez ID, de Batlle J, Torres G, Gonzalez J, de Gonzalo-Calvo D, Targa ADS,Gort-Paniello C, Moncusi-Moix A, Ceccato A, Fernandez-Barat L, Ferrer R,Garcia-Gasulla D, Menendez R, Motos A, Penuelas O, Riera J, Bermejo-Martin JF,Penasco Y, Ricart P, Martin Delgado MC, Aguilera L, Rodriguez A, Boado Varela MV,Suarez-Sipmann F, Pozo-Laderas JC, Sole-Violan J, Nieto M, Novo MA, Barberan J,Amaya Villar R, Garnacho-Montero J, Garcia-Garmendia JL, Gomez JM, Lorente JA,Blandino Ortiz A, Tamayo Lomas L, Lopez-Ramos E, Ubeda A, Catalan-Gonzalez M,Sanchez-Miralles A, Martinez Varela I, Jorge Garcia RN, Franco N,Gumucio-Sanguino VD, Huerta Garcia A, Bustamante-Munguira E, Valdivia LJ,Caballero J, Gallego E, Martinez de la Gandara A, Castellanos-Ortega A, TrenadoJ, Marin-Corral J, Albaiceta GM, de la Torre MDC, Loza-Vazquez A, Vidal P, LopezMessa J, Anon JM, Carbajales Perez C, Sagredo V, Bofill N, Carbonell N, Socias L,Barbera C, Estella A, Valledor Mendez M, Diaz E, Lopez Lago A, Torres A, Barbe F;CIBERESUCICOVID Project (COV20/00110, ISCIII). Prognostic implications ofcomorbidity patterns in critically ill COVID-19 patients: A multicenter,observational study. Lancet Reg Health Eur. 2022 May 29;18:100422. doi:10.1016/j.lanepe.2022.100422. eCollection 2022 Jul. PubMed PMID: 35655660; PubMedCentral PMCID: PMC9148543.

Carrascosa MF, Cayon Hoyo S, Echeverria San-Sebastian R, Alcalde Diez I, TapiaConcha S, Campos Fernandez S, Alonso-Fernandez EM, Gonzalez-Carrero Sixto C, LoboDuro D, Sanchez Moreno L, Zabaleta-Murguiondo MA. Descending necrotizingmediastinitis from Ludwig’s angina: a life-threatening condition. Eur J ClinMicrobiol Infect Dis. 2022 Jan;41(1):181-183. doi: 10.1007/s10096-021-04347-7.Epub 2021 Sep 11. No abstract available. PubMed PMID: 34510302.

Ceccato A, Perez-Arnal R, Motos A, Barbe F, Torres A; CiberesUCICOVIDConsortium. One-year mortality after ICU admission due to COVID-19 infection.Intensive Care Med. 2022 Mar;48(3):366-368. doi: 10.1007/s00134-021-06611-y. Epub2022 Jan 18. No abstract available. PubMed PMID: 35041016; PubMed Central PMCID:PMC8764887.

De Pascale G, Antonelli M, Deschepper M, Arvaniti K, Blot K, Brown BC, deLange D, De Waele J, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M,Koulenti D, Labeau S, Lipman J, Lipovetsky F, Maseda E, Montravers P, MikstackiA, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D, Blot S; Abdominal SepsisStudy (AbSeS) group and the Trials Group of the European Society of IntensiveCare Medicine. Poor timing and failure of source control are risk factors formortality in critically ill patients with secondary peritonitis. Intensive CareMed. 2022 Nov;48(11):1593-1606. doi: 10.1007/s00134-022-06883-y. Epub 2022 Sep23. PubMed PMID: 36151335.

Del Rio-Carbajo L, Nieto-Del Olmo J, Fernandez-Ugidos P, Vidal-Cortes P.[Resuscitation strategy for patients with sepsis and septic shock]. Med Intensiva(Engl Ed). 2022 Apr;46 Suppl 1:60-71. doi: 10.1016/j.medine.2022.02.025. Spanish.PubMed PMID: 38341261.

Diaz Santos E, Mora Jimenez C, Del Rio-Carbajo L, Vidal-Cortes P. Treatment ofsevere multi-drug resistant Pseudomonas aeruginosa infections. Med Intensiva(Engl Ed). 2022 Sep;46(9):508-520. doi: 10.1016/j.medine.2022.06.014. Epub 2022Jul 12. PubMed PMID: 35840495.

Feo M, Minambres E, Suberviola B, Campos-Fernandez S, Sanchez-Arguiano J,Kislikova M, Ballesteros MA. Controlled Donation After Circulatory Death Program:Analysis and Results at a Tertiary Care Hospital. Transplant Proc. 2022Jan-Feb;54(1):70-72. doi: 10.1016/j.transproceed.2021.09.061. Epub 2021 Dec 30.PubMed PMID: 34974895.

Gonzalez-Castro A, Cuenca Fito E, Fernandez A, Escudero Acha P, RodriguezBorregan JC, Penasco Y. Combined therapy of tocilizumab and corticosteroids insevere SARS-CoV-2 disease. Med Intensiva (Engl Ed). 2022 May;46(5):285-287. doi:10.1016/j.medine.2022.02.013. Epub 2022 Feb 24. No abstract available. PubMedPMID: 35256321; PubMed Central PMCID: PMC8866085.

Gonzalez-Castro A, Cuenca Fito E, Fernandez A, Escudero Acha P, RodriguezBorregan JC, Penasco Y. First and second wave of coronavirus-19 disease: Acomparative study in patients hospitalized in an ICU of a third-level universityhospital. Med Intensiva (Engl Ed). 2022 Mar;46(3):166-168. doi:10.1016/j.medine.2021.12.008. Epub 2021 Dec 31. No abstract available. PubMedPMID: 35012891; PubMed Central PMCID: PMC8718883.

Gonzalez-Castro A, Cuenca Fito E, Fernandez A, Escudero Acha P, RodriguezBorregan JC, Penasco Y. Impact of corticosteroid therapy on the survival ofcritical COVID-19 patients admitted into an intensive care unit. Rev EspAnestesiol Reanim (Engl Ed). 2022 Feb;69(2):120-121. doi:10.1016/j.redare.2021.02.008. Epub 2022 Feb 7. No abstract available. PubMedPMID: 35168919; PubMed Central PMCID: PMC8818356.

Gonzalez-Castro A, Cuenca Fito E, Fernandez A, Ferrero Franco R, RodriguezBorregan JC, Gonzalez C. Impact of vaccination on admissions to an intensive careunit for COVID-19 in a third-level hospital. Med Intensiva (Engl Ed). 2022Jul;46(7):406-407. doi: 10.1016/j.medine.2022.05.001. Epub 2022 May 24. Noabstract available. PubMed PMID: 35662523; PubMed Central PMCID: PMC9127048.

Gonzalez-Castro A, Cuenca Fito E, Fernandez-Rodriguez A, Escudero Acha P,Rodriguez Borregan JC, Penasco Y. High flow oxygen therapy in the treatment ofSARS-CoV-2 pneumonia. Med Intensiva (Engl Ed). 2022 Feb;46(2):105-107. doi:10.1016/j.medine.2021.11.017. Epub 2021 Nov 26. No abstract available. PubMedPMID: 34887233; PubMed Central PMCID: PMC8616732.

Gonzalez-Castro A, Fernandez-Rodriguez A, Cuenca Fito E, Suberviola-Canas B,Penasco Y, Rodriguez-Borregan JC. Comparison of the characteristics of patientswith type 2 coronavirus disease and seasonal influenza admitted to an intensivecare unit. Med Intensiva (Engl Ed). 2022 Apr;46(4):226-228. doi:10.1016/j.medine.2022.02.002. Epub 2022 Feb 9. No abstract available. PubMedPMID: 35183494; PubMed Central PMCID: PMC8850187.

Gonzalez-Castro A, Modesto I Alapont V, Fernandez A, Medina Villanueva A,Cuenca Fito E, Penasco Y. What is the pressure to follow?: Driving pressureversus Tidal pressure. Med Intensiva (Engl Ed). 2022 Dec;46(12):722-723. doi:10.1016/j.medine.2022.04.017. Epub 2022 Nov 14. No abstract available. PubMedPMID: 36396596.

Ocampo-Quintero N, Vidal-Cortes P, Del Rio Carbajo L, Fdez-Riverola F,Reboiro-Jato M, Glez-Pena D. Enhancing sepsis management through machine learningtechniques: A review. Med Intensiva (Engl Ed). 2022 Mar;46(3):140-156. doi:10.1016/j.medine.2020.04.015. PubMed PMID: 35221003.

Suberviola B, Cuenca Fito E. Management of hyperinflammation in COVID-19patients. Rev Esp Quimioter. 2022 Oct;35 Suppl 3(Suppl 3):6-9. doi:10.37201/req/s03.02.2022. Epub 2022 Oct 24. PubMed PMID: 36285849; PubMed CentralPMCID: PMC9717453.

Torres A, Motos A, Ceccato A, Bermejo-Martin J, de Gonzalo-Calvo D, Perez R,Barroso M, Pascual IZ, Gonzalez J, Fernandez-Barat L, Ferrer R, Riera J,Garcia-Gasulla D, Penuelas O, Lorente JA, Almansa R, Menendez R, Kiarostami K,Canseco J, Villar RA, Anon JM, Marino AB, Barbera C, Barberan J, Ortiz AB, BoadoMV, Bustamante-Munguira E, Caballero J, Canton-Bulnes ML, Perez CC, Carbonell N,Catalan-Gonzalez M, de Frutos R, Franco N, Galban C, Gumucio-Sanguino VD, TorreMDC, Diaz E, Estella A, Gallego E, Garmendia JLG, Gomez JM, Huerta A, Garcia RNJ,Loza-Vazquez A, Marin-Corral J, Delgado MCM, Gandara AM, Varela IM, Messa JL,Albaiceta GM, Nieto M, Novo MA, Penasco Y, Perez-Garcia F, Pozo-Laderas JC,Ricart P, Sagredo V, Sanchez-Miralles A, Chinesta SS, Serra-Fortuny M, Socias L,Sole-Violan J, Suarez-Sipmann F, Lomas LT, Trenado J, Ubeda A, Valdivia LJ, VidalP, Barbe F; CIBERESUCICOVID Project (COV20/00110, ISCIII). Methodology of a LargeMulticenter Observational Study of Patients with COVID-19 in Spanish IntensiveCare Units. Arch Bronconeumol. 2022 Apr;58 Suppl 1:22-31. doi:10.1016/j.arbres.2022.03.010. Epub 2022 Apr 15. PubMed PMID: 35491287; PubMedCentral PMCID: PMC9012512.

Torres A, Motos A, Cilloniz C, Ceccato A, Fernandez-Barat L, Gabarrus A,Bermejo-Martin J, Ferrer R, Riera J, Perez-Arnal R, Garcia-Gasulla D, Penuelas O,Lorente JA, de Gonzalo-Calvo D, Almansa R, Menendez R, Palomeque A, Villar RA,Anon JM, Balan Marino A, Barbera C, Barberan J, Blandino Ortiz A, Boado MV,Bustamante-Munguira E, Caballero J, Canton-Bulnes ML, Carbajales Perez C,Carbonell N, Catalan-Gonzalez M, de Frutos R, Franco N, Galban C,Gumucio-Sanguino VD, de la Torre MDC, Diaz E, Estella A, Gallego E, GarciaGarmendia JL, Gomez JM, Huerta A, Garcia RNJ, Loza-Vazquez A, Marin-Corral J,Martin Delgado MC, Martinez de la Gandara A, Martinez Varela I, Lopez Messa J,Albaiceta GM, Nieto M, Novo MA, Penasco Y, Perez-Garcia F, Pozo-Laderas JC,Ricart P, Sagredo V, Sanchez-Miralles A, Sancho Chinesta S, Serra-Fortuny M,Socias L, Sole-Violan J, Suarez-Sipmann F, Tamayo Lomas L, Trenado J, Ubeda A,Valdivia LJ, Vidal P, Barbe F; CIBERESUCICOVID Project Investigators. Majorcandidate variables to guide personalised treatment with steroids in criticallyill patients with COVID-19: CIBERESUCICOVID study. Intensive Care Med. 2022Jul;48(7):850-864. doi: 10.1007/s00134-022-06726-w. Epub 2022 Jun 21. PubMedPMID: 35727348; PubMed Central PMCID: PMC9211796.

Vidal-Cortes P, Martin MC, Diaz E, Bodi M, Igeno JC, Garnacho-Montero J.Impact of one year of pandemic on Spanish Intensive Care Units. Rev EspQuimioter. 2022 Aug;35(4):392-400. doi: 10.37201/req/025.2022. Epub 2022 Jun 9.PubMed PMID: 35678324; PubMed Central PMCID: PMC9333115.

Vidal-Cortes P, Martin-Loeches I, Rodriguez A, Bou G, Canton R, Diaz E, De laFuente C, Torre-Cisneros J, Nuvials FX, Salavert M, Aguilar G, Nieto M, RamirezP, Borges M, Soriano C, Ferrer R, Maseda E, Zaragoza R. Current Positioningagainst Severe Infections Due to Klebsiella pneumoniae in HospitalizedAdults. Antibiotics (Basel). 2022 Aug 27;11(9):1160. doi:10.3390/antibiotics11091160. PubMed PMID: 36139940; PubMed Central PMCID:PMC9495006.

Carbonell R, Moreno G, Martin-Loeches I, Gomez-Bertomeu F, Sarvise C, Gomez J,Bodi M, Diaz E, Papiol E, Trefler S, Nieto M, Estella A, Jimenez Herrera M, VidalCortes P, Guardiola JJ, Sole-Violan J, Rodriguez A. Prognostic Value ofProcalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with SevereInfluenza Pneumonia. Antibiotics (Basel). 2021 Mar 26;10(4):350. doi:10.3390/antibiotics10040350. PubMed PMID: 33810263; PubMed Central PMCID:PMC8066504.

Cuenca Fito E, Ots Ruiz E, Holanda Pena MS. Spontaneus gas gangrene due toClostridium septicum in a neutropenic patient. Med Clin (Barc). 2021 Dec10;157(11):e337-e338. doi: 10.1016/j.medcli.2020.12.029. Epub 2021 Mar 22. Noabstract available. English, Spanish. PubMed PMID: 33766417.

Diaz E, Amezaga Menendez R, Vidal Cortes P, Escapa MG, Suberviola B, SerranoLazaro A, Marcos Neira P, Quintana Diaz M, Catalan Gonzalez M. [Pharmacologicaltreatment of COVID-19: Narrative review of the Working Group in InfectiousDiseases and Sepsis (GTEIS) and the Working Groups in Transfusions and BloodProducts (GTTH)]. Med Intensiva. 2021 Mar;45(2):104-121. doi:10.1016/j.medin.2020.06.017. Epub 2020 Jul 11. Spanish. PubMed PMID: 38620757;PubMed Central PMCID: PMC7833076.

Escudero-Acha P, Leizaola O, Lazaro N, Cordero M, Cossio AM, Ballesteros D,Recena P, Tizon AI, Palomo M, Misis Del Campo M, Freita S, Duerto J, Mas BilbaoN, Vidal B, Gonzalez-Romero D, Diaz-Dominguez F, Revuelto J, Blasco ML, DomezainM, Pavia-Pesquera MAC, Perez Ruiz M, Pobo A, Gomez-Acebo I, Gonzalez-Castro A;Grupo de Trabajo ADENI. Limiting ICU admission from emergency services and wards.Med Clin (Barc). 2021 Dec 10;157(11):524-529. doi: 10.1016/j.medcli.2020.08.021.Epub 2021 Jan 7. English, Spanish. PubMed PMID: 33423823.

Escudero-Acha P, Penasco Y, Rodriguez-Borregan JC, Cuenca Fito E, FerreiraFreire L, Gonzalez-Castro A. Concordance between the oncologist and theintensivist in the decisions of aggressive measures in cancer patients. MedIntensiva (Engl Ed). 2021 May;45(4):246-247. doi: 10.1016/j.medin.2019.08.001.Epub 2019 Oct 17. No abstract available. English, Spanish. PubMed PMID: 31630915.

Escudero-Acha P, Penasco Y, Rodriguez-Borregan JC, Cuenca Fito E, FerreiraFreire L, Gonzalez-Castro A. Concordance between the oncologist and theintensivist in the decisions of aggressive measures in cancer patients. MedIntensiva (Engl Ed). 2021 May;45(4):246-247. doi: 10.1016/j.medin.2019.08.001.Epub 2019 Oct 17. No abstract available. English, Spanish. PubMed PMID: 31630915.

Estella A, Vidal-Cortes P, Rodriguez A, Andaluz Ojeda D, Martin-Loeches I,Diaz E, Suberviola B, Gracia Arnillas MP, Catalan Gonzalez M, Alvarez-Lerma F,Ramirez P, Nuvials X, Borges M, Zaragoza R. Management of infectiouscomplications associated with coronavirus infection in severe patients admittedto ICU. Med Intensiva (Engl Ed). 2021 Nov;45(8):485-500. doi:10.1016/j.medine.2021.08.013. Epub 2021 Aug 24. PubMed PMID: 34475008; PubMedCentral PMCID: PMC8382590.

Gonzalez-Castro A, Cuenca Fito E, Fernandez-Rodriguez A, Escudero Acha P,Rodriguez Borregan JC, Penasco Y. High flow oxygen therapy in the treatment ofSARS-CoV-2 pneumonia. Med Intensiva (Engl Ed). 2021 Jan 18;46(2):105-7. doi:10.1016/j.medin.2020.12.004. Online ahead of print. No abstract available.English, Spanish. PubMed PMID: 33551112; PubMed Central PMCID: PMC7816877.

Gonzalez-Castro A, Cuenca Fito E, Fernandez-Rodriguez A, Escudero Acha P,Rodriguez Borregan JC, Penasco Y. High flow oxygen therapy in the treatment ofSARS-CoV-2 pneumonia. Med Intensiva (Engl Ed). 2021 Jan 18;46(2):105-7. doi:10.1016/j.medin.2020.12.004. Online ahead of print. No abstract available.English, Spanish. PubMed PMID: 33551112; PubMed Central PMCID: PMC7816877.

Gonzalez-Castro A, Escudero Acha P, Rodriguez Borregan JC, Penasco Y, BlancoHuelga C, Cuenca Fito E. Combination of airway pressure release ventilation withinverted inspiration-exhalation ratio and low-flow CO2 removal deviceswith renal replacement therapy in refractory hypoxemia. Med Intensiva (Engl Ed).2021 Aug-Sep;45(6):376-379. doi: 10.1016/j.medine.2021.05.001. Epub 2021 May 28.No abstract available. PubMed PMID: 34053911; PubMed Central PMCID: PMC8160289.

Gonzalez-Castro A, Medina A, Modesto I Alapont V, Cuenca-Fito E,Fernandez-Rodriguez A, Penasco Y. The need for rigorous analysis of theeffectiveness and efficiency of high flow oxygen therapy during the SARS-CoV-2pandemic. Med Intensiva (Engl Ed). 2021 Nov;45(8):508-509. doi:10.1016/j.medine.2021.08.010. Epub 2021 Aug 21. No abstract available. PubMedPMID: 34475009; PubMed Central PMCID: PMC8379083.

Martin-Loeches I, Motos A, Menendez R, Gabarrus A, Gonzalez J, Fernandez-BaratL, Ceccato A, Perez-Arnal R, Garcia-Gasulla D, Ferrer R, Riera J, Lorente JA,Penuelas O, Bermejo-Martin JF, de Gonzalo-Calvo D, Rodriguez A, Barbe F, AguileraL, Amaya-Villar R, Barbera C, Barberan J, Blandino Ortiz A, Bustamante-MunguiraE, Caballero J, Carbajales C, Carbonell N, Catalan-Gonzalez M, Galban C,Gumucio-Sanguino VD, de la Torre MDC, Diaz E, Gallego E, Garcia Garmendia JL,Garnacho-Montero J, Gomez JM, Jorge Garcia RN, Loza-Vazquez A, Marin-Corral J,Martinez de la Gandara A, Martinez Varela I, Lopez Messa J, Albaiceta GM, NovoMA, Penasco Y, Ricart P, Urrelo-Cerron L, Sanchez-Miralles A, Sancho Chinesta S,Socias L, Sole-Violan J, Tamayo Lomas L, Vidal P, Torres A. ICU-AcquiredPneumonia Is Associated with Poor Health Post-COVID-19 Syndrome. J Clin Med. 2021Dec 31;11(1):224. doi: 10.3390/jcm11010224. PubMed PMID: 35011967; PubMed CentralPMCID: PMC8746263.

Moreno G, Carbonell R, Martin-Loeches I, Sole-Violan J, Correig I Fraga E,Gomez J, Ruiz-Botella M, Trefler S, Bodi M, Murcia Paya J, Diaz E, Vidal-CortesP, Papiol E, Albaya Moreno A, Sancho Chinesta S, Socias Crespi L, Lorente MDC,Loza Vazquez A, Vara Arlanzon R, Recio MT, Ballesteros JC, Ferrer R, FernandezRey E, Restrepo MI, Estella A, Margarit Ribas A, Guasch N, Reyes LF, Marin-CorralJ, Rodriguez A; COVID-19 SEMICYUC Working Group. Corticosteroid treatment andmortality in mechanically ventilated COVID-19-associated acute respiratorydistress syndrome (ARDS) patients: a multicentre cohort study. Ann IntensiveCare. 2021 Nov 26;11(1):159. doi: 10.1186/s13613-021-00951-0. PubMed PMID:34825976; PubMed Central PMCID: PMC8617372.

Sakr Y, Francois B, Sole-Violan J, Kotfis K, Jaschinski U, Estella A, Leone M,Jakob SM, Wittebole X, Fontes LE, de Melo Gurgel M, Midega T, Vincent JL, RanieriVM; SOAP and ICON Investigators. Temporal changes in the epidemiology,management, and outcome from acute respiratory distress syndrome in Europeanintensive care units: a comparison of two large cohorts. Crit Care. 2021 Feb25;25(1):87. doi: 10.1186/s13054-020-03455-8. PubMed PMID: 33632247; PubMedCentral PMCID: PMC7906083.

Torres A, Motos A, Riera J, Fernandez-Barat L, Ceccato A, Perez-Arnal R,Garcia-Gasulla D, Penuelas O, Lorente JA, Rodriguez A, de Gonzalo-Calvo D,Almansa R, Gabarrus A, Menendez R, Bermejo-Martin JF, Ferrer R, Amaya Villar R,Anon JM, Barbera C, Barberan J, Blandino Ortiz A, Bustamante-Munguira E,Caballero J, Carbajales C, Carbonell N, Catalan-Gonzalez M, Galban C,Gumucio-Sanguino VD, de la Torre MDC, Diaz E, Estella A, Gallego E, GarciaGarmendia JL, Garnacho-Montero J, Gomez JM, Huerta A, Jorge Garcia RN,Loza-Vazquez A, Marin-Corral J, Martinez de la Gandara A, Martinez Varela I,Lopez Messa J, M Albaiceta G, Novo MA, Penasco Y, Pozo-Laderas JC, Ricart P,Salvador-Adell I, Sanchez-Miralles A, Sancho Chinesta S, Socias L, Sole-Violan J,Suares Sipmann F, Tamayo Lomas L, Trenado J, Barbe F; CIBERESUCICOVID Project(COV20/00110, ISCIII). The evolution of the ventilatory ratio is a prognosticfactor in mechanically ventilated COVID-19 ARDS patients. Crit Care. 2021 Sep13;25(1):331. doi: 10.1186/s13054-021-03727-x. PubMed PMID: 34517881; PubMedCentral PMCID: PMC8436582.

Vidal-Cortes P, Del Rio-Carbajo L, Nieto-Del Olmo J, Prol-Silva E,Tizon-Varela AI, Rodriguez-Vazquez A, Rodriguez-Rodriguez P, Diaz-Lopez MD,Fernandez-Ugidos P, Perez-Veloso MA. COVID-19 and Acute Respiratory DistressSyndrome. Impact of corticosteroid treatment and predictors of poor outcome. RevEsp Quimioter. 2021 Feb;34(1):33-43. doi: 10.37201/req/091.2020. Epub 2020 Dec15. PubMed PMID: 33317261; PubMed Central PMCID: PMC7876902.

Vidal-Cortes P, Del Rio-Carbajo L, Nieto-Del Olmo J, Prol-Silva E,Tizon-Varela AI, Rodriguez-Vazquez A, Rodriguez-Rodriguez P, Diaz-Lopez MD,Fernandez-Ugidos P, Perez-Veloso MA. COVID-19 and Acute Respiratory DistressSyndrome. Impact of corticosteroid treatment and predictors of poor outcome. RevEsp Quimioter. 2021 Feb;34(1):33-43. doi: 10.37201/req/091.2020. Epub 2020 Dec15. PubMed PMID: 33317261; PubMed Central PMCID: PMC7876902.

Vidal-Cortes P, Nuvials-Casals X, Maseda-Garrido E, Sancho-Chinesta S,Suberviola-Canas B, Gonzalez-Castro R, Nieto-Cabrera M, Diaz-Santos E, Aguilar G.Organization of attention to infectious pathology in critical care units inSpain. Med Intensiva (Engl Ed). 2021 Nov;45(8):e25-e28. doi:10.1016/j.medine.2020.08.008. No abstract available. PubMed PMID: 34717885.

Vogelaers D, Blot S, Van den Berge A, Montravers P; Abdominal Sepsis Study(‘AbSeS’) Group on behalf of the Trials Group of the European Society ofIntensive Care Medicine. Antimicrobial Lessons From a Large Observational Cohorton Intra-abdominal Infections in Intensive Care Units. Drugs. 2021Jun;81(9):1065-1078. doi: 10.1007/s40265-021-01534-w. Epub 2021 May 26. PubMedPMID: 34037963.

Ballesteros Sanz MA, Hernandez-Tejedor A, Estella A, Jimenez Rivera JJ,Gonzalez de Molina Ortiz FJ, Sandiumenge Camps A, Vidal Cortes P, de Haro C,Aguilar Alonso E, Bordeje Laguna L, Garcia Saez I, Bodi M, Garcia Sanchez M,Parraga Ramirez MJ, Alcaraz Penarrocha RM, Amezaga Menendez R, Burgueno Laguia P;Grupos de Trabajo de la Sociedad Espanola de Medicina Intensiva, Critica yUnidades Coronarias (SEMICYUC); Grupos de Trabajo de la Sociedad Espanola deMedicina Intensiva, Critica y Unidades Coronarias. Grupo de Trabajo de Bioetica;Grupo de Trabajo de Cuidados Intensivos Cardiologicos y RCP; Grupo de Trabajo deCuidados Intensivos Nefrologicos; Grupo de Trabajo de Donacion y Trasplantes;Grupo de Trabajo de Enfermedades Infecciosas y Sepsis; Grupo de Trabajo deEvaluacion de Tecnologias y Metodologia de la Investigacion; Grupo de Trabajo deInsuficiencia Respiratoria Aguda; Grupo de Trabajo de Metabolismo y Nutricion;Grupo de Trabajo de Neurointensivismo y Trauma; Grupo de Trabajo dePlanificacion, Organizacion y Gestion; Grupo de Trabajo de Sedacion, Analgesia yDelirio; Grupo de Trabajo de Simulacion; Grupo de Trabajo de Toxicologia; Grupode Trabajo de Transfusiones y Hemoderivados; Grupo de Trabajo de TransporteCritico; Junta Directiva. Recommendations of the Working Groups from the SpanishSociety of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) forthe management of adult critically ill patients in the coronavirus disease(COVID-19). Med Intensiva (Engl Ed). 2020 Aug-Sep;44(6):371-388. doi:10.1016/j.medin.2020.04.001. Epub 2020 Apr 8. PubMed PMID: 32360034; PubMedCentral PMCID: PMC7340388.

De Bus L, Depuydt P, Steen J, Dhaese S, De Smet K, Tabah A, Akova M, Cotta MO,De Pascale G, Dimopoulos G, Fujitani S, Garnacho-Montero J, Leone M, Lipman J,Ostermann M, Paiva JA, Schouten J, Sjovall F, Timsit JF, Roberts JA, Zahar JR,Zand F, Zirpe K, De Waele JJ; DIANA study group. Antimicrobial de-escalation inthe critically ill patient and assessment of clinical cure: the DIANA study.Intensive Care Med. 2020 Jul;46(7):1404-1417. doi: 10.1007/s00134-020-06111-5.Epub 2020 Jun 9. PubMed PMID: 32519003; PubMed Central PMCID: PMC7334278.

Impact of the elderly donor on an abdominal organ transplantation program. María Ángeles Ballesteros MD, PhD, Borja Suberviola MD, PhD, Lara Belmar Vega MD, Roberto Fernández-Santiago MD, Sandra Campos Fernández MD, Juan Carlos Ruiz San Millán MD, PhD & Eduardo Miñambres MD, PhD.

Perez-San Martin S, Suberviola B, Garcia-Unzueta MT, Lavin BA, Campos S,Santibanez M. Prognostic value of plasma pentraxin 3 levels in patients withseptic shock admitted to intensive care. PLoS One. 2020 Dec 10;15(12):e0243849.doi: 10.1371/journal.pone.0243849. eCollection 2020. PubMed PMID: 33301518;PubMed Central PMCID: PMC7728227.

Vidal-Cortes P, Alvarez-Rocha LA, Fernandez-Ugidos P, Perez-Veloso MA,Suarez-Paul IM, Virgos-Pedreira A, Pertega-Diaz S, Castro-Iglesias AC.Epidemiology and outcome of HIV-infected patients admitted to the ICU in thecurrent highly active antiretroviral therapy era. Med Intensiva (Engl Ed). 2020Jun-Jul;44(5):283-293. doi: 10.1016/j.medin.2019.02.012. Epub 2019 Apr 7.English, Spanish. PubMed PMID: 30971339.

Vidal-Cortes P, Alvarez-Rocha LA, Fernandez-Ugidos P, Perez-Veloso MA,Suarez-Paul IM, Virgos-Pedreira A, Pertega-Diaz S, Castro-Iglesias AC.Epidemiology and outcome of HIV-infected patients admitted to the ICU in thecurrent highly active antiretroviral therapy era. Med Intensiva (Engl Ed). 2020Jun-Jul;44(5):283-293. doi: 10.1016/j.medin.2019.02.012. Epub 2019 Apr 7.English, Spanish. PubMed PMID: 30971339.

Vincent JL, Ferguson A, Pickkers P, Jakob SM, Jaschinski U, Almekhlafi GA,Leone M, Mokhtari M, Fontes LE, Bauer PR, Sakr Y; ICON Investigators. Theclinical relevance of oliguria in the critically ill patient: analysis of a largeobservational database. Crit Care. 2020 Apr 23;24(1):171. doi:10.1186/s13054-020-02858-x. PubMed PMID: 32326981; PubMed Central PMCID:PMC7181534.

Zaragoza R, Vidal-Cortes P, Aguilar G, Borges M, Diaz E, Ferrer R, Maseda E,Nieto M, Nuvials FX, Ramirez P, Rodriguez A, Soriano C, Veganzones J,Martin-Loeches I. Update of the treatment of nosocomial pneumonia in the ICU.Crit Care. 2020 Jun 29;24(1):383. doi: 10.1186/s13054-020-03091-2. PubMed PMID:32600375; PubMed Central PMCID: PMC7322703.